White House Forms Life Sciences Panel

WASHINGTON—White House science adviser William Graham has formed a new committee to shape administration policy in the life sciences. The 24-member coordinating committee will be chaired by Beverly Berger, assistant director for life sciences in the Office of Science and Technology Policy. It will consist of representatives from nine Cabinet-level departments and nine federal agencies, including several with the duty to regulate rather than finance research in the life sciences. The co

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WASHINGTON—White House science adviser William Graham has formed a new committee to shape administration policy in the life sciences.

The 24-member coordinating committee will be chaired by Beverly Berger, assistant director for life sciences in the Office of Science and Technology Policy. It will consist of representatives from nine Cabinet-level departments and nine federal agencies, including several with the duty to regulate rather than finance research in the life sciences.

The committee will exist alongside the three-year-old Biotechnology Science Coordinating Committee, created to resolve the differing views within the federal government on regulating biotechnology. BSCC has a new chairman, NIH Director James Wyngaarden. He replaces David Kingsbury, NSF assistant director for biological, behavioral and social sciences, who was forced out in October by Graham. NSF’s slot on the committee has been filled by Deputy Director John Moore.

“Our scope is very broad,” Berger said about her committee’s charter. “We plan ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies